Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human IFITM5 Protein, N-His-KSI

Catalog #:   YHA01101 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: A6NNB3
Protein length: [Asp2-Leu37] & [Leu57-Ile87] & [Gly107-Asp132]
Overview

Catalog No.

YHA01101

Expression system

E. coli

Species

Homo sapiens (Human)

Protein length

[Asp2-Leu37] & [Leu57-Ile87] & [Gly107-Asp132]

Predicted molecular weight

26.15 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

A6NNB3

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Interferon-induced transmembrane protein 5, Bone-restricted interferon-induced transmembrane protein-like protein, BRIL, Dispanin subfamily A member 1, DSPA1, IFITM5

Data Image
  • SDS-PAGE
    SDS-PAGE for Recombinant Human IFITM5 protein
References

Osteogenesis imperfecta type V: About a clinical case., PMID:40379599

Genetic landscape and phenotypic spectrum of osteogenesis imperfecta in the Kazakhstani pediatric population., PMID:40175636

Brittle, but not boring: a fresh look at osteogenesis imperfecta type V., PMID:40068302

An inducible mouse model of osteogenesis imperfecta type V reveals aberrant osteogenesis caused by Ifitm5 c.-14C>T mutation., PMID:39908237

Identification of human cranio-maxillofacial skeletal stem cells for mandibular development., PMID:39742474

Rare diseases: a challenge in paediatric dentistry., PMID:39212455

Update on the Genetics of Osteogenesis Imperfecta., PMID:39127989

Genotype and Phenotype Correlation of Patients with Osteogenesis Imperfecta., PMID:39025364

Effectiveness of whole exome sequencing analyses in the molecular diagnosis of osteogenesis imperfecta., PMID:38953412

The IFITM5 mutation in osteogenesis imperfecta type V is associated with an ERK/SOX9-dependent osteoprogenitor differentiation defect., PMID:38885336

Exome sequencing identified mutations in the WNT1 and COL1A2 genes in osteogenesis imperfecta cases., PMID:38536562

Echocardiographic abnormalities and joint hypermobility in Chinese patients with Osteogenesis imperfecta., PMID:38475860

Role of interferon-induced transmembrane protein family in cancer progression: a special focus on pancreatic cancer., PMID:38472606

Weighted burden analysis of rare coding variants in 470,000 exome-sequenced UK Biobank participants characterises effects on hyperlipidaemia risk., PMID:38454133

Role of IFITM2 in osteogenic differentiation of C3H10T1/2 mesenchymal stem cells., PMID:38404731

Association of Antenatal Evaluations with Postmortem and Genetic Findings in the Series of Fetal Osteogenesis Imperfecta., PMID:38346409

Transcriptome Sequencing of Gingival Tissues from Impacted Third Molars Patients Reveals the Alterations of Gene Expression., PMID:38178683

Assessing type I collagen expression and quality in cellular models of osteogenesis imperfecta., PMID:38014644

The IFITM5 Ser40Leu variant can manifest as prenatal Caffey disease., PMID:37799085

DMP1 and IFITM5 Regulate Osteogenic Differentiation of MC3T3-E1 on PEO-Treated Ti-6Al-4V-Ca2+/Pi surface., PMID:36802481

Abnormal signal pathways and tumor heterogeneity in osteosarcoma., PMID:36759884

Genetic analysis of osteogenesis imperfecta in a large Brazilian cohort., PMID:36709916

Identification of novel prognostic biomarkers for osteosarcoma: a bioinformatics analysis of differentially expressed genes in the mesenchymal stem cells from single-cell sequencing data set., PMID:36388032

Does the c.-14C>T Mutation in the IFITM5 Gene Provide Identical Phenotypes for Osteogenesis Imperfecta Type V? Data from Russia and a Literature Review., PMID:36289625

Alterations of bone material properties in growing Ifitm5/BRIL p.S42 knock-in mice, a new model for atypical type VI osteogenesis imperfecta., PMID:35654352

Genotype-Phenotype Relationship and Follow-up Analysis of a Chinese Cohort With Osteogenesis Imperfecta., PMID:35550181

The Osteogenesis Imperfecta Type V Mutant BRIL/IFITM5 Promotes Transcriptional Activation of MEF2, NFATc, and NR4A in Osteoblasts., PMID:35216266

Osteogenesis Imperfecta: Search for Mutations in Patients from the Republic of Bashkortostan (Russia)., PMID:35052464

Specific Characteristic of Hyperplastic Callus in a Larger Cohort of Osteogenesis Imperfecta Type V., PMID:34988594

Osteogenesis imperfecta in 140 Turkish families: Molecular spectrum and, comparison of long-term clinical outcome of those with COL1A1/A2 and biallelic variants., PMID:34902613

An Unusual Presentation of Osteogenesis Imperfecta: A Case Report., PMID:34807880

Integrative overview of IFITMs family based on Bioinformatics analysis., PMID:34466338

A Novel IFITM5 Variant Associated with Phenotype of Osteoporosis with Calvarial Doughnut Lesions: A Case Report., PMID:34156493

Calvaria Bone Transcriptome in Mouse Models of Osteogenesis Imperfecta., PMID:34069814

Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types., PMID:34007986

Genetic analysis in Japanese patients with osteogenesis imperfecta: Genotype and phenotype spectra in 96 probands., PMID:33939306

Coalescing expansile skeletal disease: Delineation of an extraordinary osteopathy involving the IFITM5 mutation of osteogenesis imperfecta type V., PMID:33360005

Effect of immunosuppressants on a mouse model of osteogenesis imperfecta type V harboring a heterozygous Ifitm5 c.-14C > T mutation., PMID:33273604

A novel variant of the IFITM5 gene within the 5'-UTR causes neonatal transverse clavicular fracture: Expanding the genetic spectrum., PMID:32383316

Synthetic antibodies against BRIL as universal fiducial marks for single-particle cryoEM structure determination of membrane proteins., PMID:32221310

The molecular landscape of osteogenesis imperfecta in a Brazilian tertiary service cohort., PMID:32123938

Osteogenesis imperfecta in a male holstein calf associated with a possible oligogenic origin., PMID:31980012

The IFITM protein family in adaptive immunity., PMID:31792954

[Prenatal gene diagnosis of 200 fetuses at high risk of osteogenesis imperfect]., PMID:31715670

Bruck syndrome 2 variant lacking congenital contractures and involving a novel compound heterozygous PLOD2 mutation., PMID:31472299

Analysis of IFITM-IFITM Interactions by a Flow Cytometry-Based FRET Assay., PMID:31398796

Comprehensive genetic analyses using targeted next-generation sequencing and genotype-phenotype correlations in 53 Japanese patients with osteogenesis imperfecta., PMID:31363794

Altered gene expression profiles of the MDA5 signaling pathway in peripheral blood lymphocytes of chickens infected with avian reovirus., PMID:31273469

Expanding the Clinical Spectrum of Osteogenesis Imperfecta Type V: 13 Additional Patients and Review., PMID:31244780

IFITM5 pathogenic variant causes osteogenesis imperfecta V with various phenotype severity in Ukrainian and Vietnamese patients., PMID:31159867

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human IFITM5 Protein, N-His-KSI [YHA01101]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only